Home NDC 17856-1008-2 NDC 17856-1008-2 - Nystatin This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 17856-1008
Requested NDC 17856-1008-2
Package NDCs from labels 17856-1008-2, 17856-1008-1
Manufacturer ATLANTIC BIOLOGICALS CORP.
Effective date 2023-01-19
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type NYSTATIN ORAL SUSPENSION, USP ATLANTIC BIOLOGICALS CORP. 2023-01-19 HUMAN PRESCRIPTION DRUG LABEL
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 17856-1008-1 Nystatin 72 in 1 BOX, UNIT-DOSE SUSPENSION 72 1 17856-1008-2 Nystatin 5 mL in 1 CUP, UNIT-DOSE SUSPENSION 5 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 17856-1008 NYSTATIN SUSPENSION [ATLANTIC BIOLOGICALS CORP.] 1 2 package rows 20230120_5a07151e-0a9f-4ca5-b7b2-d954e8c33a27.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 13 of 177 · 3,521 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.